Table 3.
Variable | 95% confidence
|
||
---|---|---|---|
Risk ratio | Interval | P | |
Surgery alone group (n = 31) | |||
Gender | 1.6 | 0.53–4.9 | 0.39 |
Age (years) | 1.0 | 0.97–1.1 | 0.46 |
Stage | 1.1 | 0.51–2.4 | 0.79 |
KGFR | 5.2 | 0.57–47 | 0.14 |
KGF | 0.74 | 0.18–3.1 | 0.68 |
VEGF-A | 0.69 | 0.20–2.4 | 0.55 |
Coexpression of KGFR and KGF | 15 | 1.1–189 | 0.039 |
Overall patients (n = 53) | |||
Gender | 1.4 | 0.61–3.4 | 0.41 |
Age (years) | 1.0 | 0.98–1.1 | 0.34 |
Stage | 1.6 | 0.87–2.9 | 0.13 |
KGFR | 3.7 | 0.96–14 | 0.058 |
KGF | 1.6 | 0.53–5.0 | 0.40 |
VEGF-A | 1.9 | 0.76–4.5 | 0.17 |
Coexpression of KGFR and KGF | 7.5 | 1.2–46 | 0.028 |